The Betulin Project: Introduction 2014 by Snyder, John K.
Boston University
OpenBU http://open.bu.edu
Chemistry The Betulin Project
2014








betulinic	  acid	  were	  later	  reports	  of	  its	  activity	  against	  HIV.3	  	  	   The	   excitement	   triggered	  by	   the	   anti-­‐melanoma	   activity	   of	   betulinic	   acid	   has	   long	  been	  tempered	  by	  its	  very	  poor	  bioavailability	  caused	  by	  its	  very	  high	  level	  of	  lipophilicity	  (it	  is	  very	  hydrocarbon-­‐like).	  Medicinal	  chemists	  have	  been	  preparing	  derivatives	  for	  a	  long	  time	  in	  an	  attempt	  to	  discover	  equally	  effective	  analogues,	  but	  with	  better	  water	  solubility,	  and	  hence	  better	  bioavailability.	  In	  addition,	  these	  efforts	  to	  alter	  or	  “decorate”	  around	  the	  betulinic	  acid	  structure	  have	  led	  to	  a	  better	  understanding	  of	  which	  functional	  groups	  of	  2	  are	  required	  for	  bioactivity.	  For	  example,	  it	  is	  now	  known	  that	  the	  C-­‐28	  carboxylic	  acid	  is	  required	   (betulin	   itself	   is	   not	   active	   against	   melanoma,	   for	   example,	   and	   neither	   are	  esterified	   betulinic	   acid	   derivatives),	   and	   the	   C-­‐3	   α-­‐stereoisomer	   4	   is	   significantly	   less	   active	   than	   2.	   In	  addition,	   the	   activity	   of	   betulinic	   acid	   has	   spurred	  numerous	   investigations	   for	   the	   synthetic	   conversion	   of	  
1,	  which	  is	  very	  abundant	  and	  inexpensive,	  into	  2,	  which	  is	   relatively	   scarce	   and	   expensive	   (Scheme	   1).	   This	  
conversion,	  however,	  is	  not	  stereoselective	  at	  C-­‐3	  in	  the	  reduction	  step.	  A	  direct	  oxidation	  of	  betulin	  to	  betulinic	  acid	  has	  also	  been	  reported.4	  	   In	  this	  project	  you	  will	  begin	  with	  the	  isolation	  of	  betulin	  from	  the	  bark	  of	  the	  white	  birch	   collected	   locally	   (Harvard,	   MA),	   then	   use	   the	   betulin	   you’ve	   isolated	   to	   make	  derivatives	   that	   ultimately	   derivatize	   and	   remodel	   the	  basic	   structure.	  A	  primary	   goal	   in	  this	   chemistry	   will	   be	   the	   incorporation	   of	   nitrogen	   into	   the	   betulin	   framework.	   The	  derivatives	   targeted	   are	   designed	   to	   both	   illustrate	   basic	   reactions	   and	   principles	   in	  organic	   synthesis,	   as	  well	   as	   to	   build	   a	   small	   library	   of	   betulin	   derivatives	   for	   biological	  screening.	   Ultimately,	   the	   goal	   is	   to	   have	   you	   develop	   your	   own	   ideas	   that	   extend	   the	  chemistry	   carried	   out	   this	   semester	   in	   a	   direction	   that	   intrigues	   you.	   These	   further	  laboratory	  explorations	  could	  pursue	  other	  analogues	  of	  betulinic	  acid	  that	  would	  improve	  bioavailability	  (this	  is	  a	  popular	  endeavor,	  so	  one	  needs	  to	  be	  aware	  of	  the	  literature	  before	  pursuing	  such	  goals),	  further	  probe	  structural	  requirements	  for	  bioactivity	  (the	  bioactivity	  need	   not	   be	   “anticancer”,	   but	   any	   activity	   discovered	   in	   a	   biological	   screen),	   or	   even	  remodel	  the	  basic	  lupane	  skeleton	  of	  betulin	  itself	  to	  generate	  new,	  complex	  “unnatural”	  or	  “remodeled”	  natural	   products.	   You	  may	   also	  wish	   to	  pursue	   the	   conversion	  of	   betulin	   to	  betulinic	   acid,	   then	   use	   betulinic	   acid	   as	   the	   starting	   material	   for	   further	   medicinal	  chemistry	  pursuits.	  	  You	  will	  be	  given	  a	  minimal	  outline	  of	  the	  goals	  of	  each	  lab,	  then	  be	  required	  to	  write	  out	  the	  procedure	  you	  intend	  to	  implement	  in	  the	  lab	  itself	  prior	  to	  the	  start	  of	  the	  pre-­‐lab	  
	  
	  
session,	  during	  which	  we	  will	  discuss	  the	  procedure(s)	  to	  employed.	  Follow	  the	  notebook	  
format	   as	   detailed	   for	   the	   regular	   organic	   chemistry	   lab.	   It	   is	   certainly	   possible	   that	  more	   than	   one	   of	   your	   procedures	   you’ve	   uncovered	   from	   the	   literature	   will	   be	  implemented	   in	   the	   lab	  by	   if	  more	  than	  one	  set	  of	  protocols	   looks	  reasonable.	  Good	   luck,	  and	   should	  your	  experiments	   fail,	   the	   chemistry	  department	  will,	   of	   course,	  disavow	  any	  prior	  knowledge	  of	  your	  mission.	  	  	  Vocabulary:	  	  triterpene	  terpenoid	  functional	  group	  alcohol	  alkene	  lupane	  triterpene	  bioavailability	  lipophilicity	  hydrocarbon	  esters	  stereoisomer	  	  Questions:	  (40	  pts	  total)	  	   1) What	  is	  the	  structure	  of	  the	  methyl	  ester	  of	  betulinic	  acid?	  2) Why	  does	  high	  lipophilicity	  reduce	  bioavailability?	  3) What	  is	  cLogP?	  4) What	  is	  the	  difference	  between	  a	  lupane	  triterpene	  and	  an	  oleane	  triterpene?	  5) What	  is	  the	  structural	  difference	  between	  2	  and	  4?	  	   In	   this	   project,	   the	   following	   experiments	   may	   be	   carried	   out,	   though	   as	   with	   all	  research	  projects,	  variations	  in	  the	  experiments	  depends	  upon	  the	  outcome	  of	  the	  previous	  experiment.	   	  These	  goals	  are	  illustrated	  in	  accompanying	  PowerPoint	  presentation,	  which	  also	  points	  out	  procedures	  attempted	  last	  year	  (Fall,	  2013)	  which	  did	  not	  work	  well,	  or	  at	  all!	  	  Experiment	  #1	  –	  Isolation	  of	  Betulin	  from	  the	  Bark	  of	  Betula	  alba	  
	  Experiment	  #2a	  –	  Monoacetylation	  of	  Betulin	  	  Experiment	  #2b	  –	  Rearrangement	  of	  Betulin	  to	  Allobetulin	  	  Experiment	  #3	  –	  Oxidation	  of	  Betulin	  Monoacetate	  (Betulone	  Monoacetate)	  	  Experiment	  #4	  –	  Oxime	  Formation	  from	  Betulone	  Monoacetate	  	  Experiment	  #5	  –	  Beckman	  Rearrangement	  of	  Betulone	  Monoacetate	  Oxime	  
	  Experiment	  #6	  –	  Reduction	  of	  A-­‐Ring	  Lactam	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